US58507V1070
US58507V1070
Medline Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 48.79B EUR | 34.59B EUR | 37.65B EUR | 34.1B EUR |
Enterprise Value | 48.8B EUR | 44.9B EUR | 48.05B EUR | 44.79B EUR |
Valuation Multiples | ||||
Trailing P/E | 90.65x | 93.23x | 121.05x | 67.67x |
Forward P/E | 23x | -- | -- | -- |
Price to Sales | 1.63x | 1.52x | 2.49x | 2.36x |
Price to Book | 2.75x | 2.99x | 3.34x | 3.18x |
EV/Revenue | 1.63x | 1.97x | 3.17x | 3.1x |
EV/EBITDA | 19.38x | 22.54x | 21.3x | 18.65x |
Price to FCF (P/FCF) | 57.35x | 34.21x | 76.21x | 44.76x |
EV/FCF | 57.37x | 44.41x | 97.26x | 58.78x |
FCF Yield | 1.74% | 2.92% | 1.31% | 2.23% |